Otsuka America, Inc.
Otsuka America, Inc., a subsidiary of Otsuka Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical and nutraceutical industries, headquartered in the United States. Established in 1973, the company has made significant strides in developing innovative treatments for mental health, nephrology, and other therapeutic areas, with a strong focus on research and development. With major operational regions across North America, Otsuka America is renowned for its unique products, including the groundbreaking antipsychotic medication Abilify and the innovative treatment for chronic kidney disease, Jynarque. The company’s commitment to advancing healthcare solutions has positioned it as a leader in the industry, marked by notable achievements in patient care and a dedication to improving quality of life.
DitchCarbon Score
How does Otsuka America, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Otsuka America, Inc.'s score of 55 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Otsuka America, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Otsuka Pharmaceutical Co., Ltd., which cascades its climate commitments and targets through its corporate family relationship. Otsuka America, Inc. inherits its climate initiatives from Otsuka Holdings Co., Ltd., which is at cascade level 2. While specific reduction targets from the Science Based Targets initiative (SBTi) are not detailed for Otsuka America, the overarching commitments from Otsuka Holdings Co., Ltd. guide the subsidiary's climate strategy. This includes participation in initiatives such as the Carbon Disclosure Project (CDP) and RE100, which aim to enhance transparency and promote renewable energy usage. As of now, Otsuka America, Inc. has not publicly outlined specific reduction targets or achievements in carbon emissions. However, the company is aligned with its parent organisation's broader sustainability goals, which focus on reducing environmental impact and enhancing climate resilience.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2016 | 2017 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 285,728,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 116,816,000 | 000,000,000 | 000,000,000 | - | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 402,544,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Otsuka America, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
